ARCHIVES

House Panel Targets AWP For Medicare Drug Pricing.

This article is from The Cancer Letter archive.

Vol. 27 No. 36 | October 5, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

NCI Objections Delay GAO Report On Cancer Control

March 7, 1980

Is the Concept of National Chain Of Outpatient Centers Still Viable?

May 2, 1997

Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal

September 3, 2010

Non-Caucasians At Higher Risk For Severe Breast Cancer Pain

December 28, 2007

Letrozole Combination Increases PFS In ER+ and HER2-Negative Breast Cancer

January 25, 2013